Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Akoya Biosciences, Inc. (AKYA) had Return on Equity of -77.26% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$18.81M |
|
$-10.53M |
|
$7.09M |
|
$11.72M |
|
$27.16M |
|
$-8.35M |
|
$-2.14M |
|
$-10.49M |
|
$-10.49M |
|
$-10.53M |
|
$-10.53M |
|
$-10.53M |
|
$-10.53M |
|
$-8.35M |
|
$-6.52M |
|
49.50M |
|
49.50M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$76.86M |
|
$7.55M |
|
$53.11M |
|
$129.97M |
|
$27.99M |
|
$76.68M |
|
$88.35M |
|
$116.34M |
|
$13.63M |
|
$-19.90M |
|
$13.63M |
|
49.52M |
|
| Cash Flow Statement Financials | |
$-41.12M |
|
$-26.74M |
|
$-2.72M |
|
$83.82M |
|
$13.24M |
|
$-70.58M |
|
$7.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.75 |
|
-- |
|
-- |
|
0.85 |
|
5.70 |
|
62.32% |
|
-44.38% |
|
-44.38% |
|
-- |
|
-55.75% |
|
-55.98% |
|
$-42.53M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.28 |
|
1.47 |
|
61.16 |
|
|
Return on Equity |
-77.26% |
52.93% |
|
-8.10% |
|
-11.66% |
|
$0.28 |
|
$-0.86 |
|
$-0.83 |
|